This e-learning course discusses treatment sequencing in advanced hepatocellular carcinoma (HCC). Key clinical questions will be addressed, including:
- What does the current systemic treatment landscape for advanced HCC look like?
- What is the role of novel systemic therapies and immunotherapy?
- What is the impact of treatment sequencing?
- What are the main adverse events associated with targeted therapy and immunotherapy, including immune-related hepatotoxicity?
- What will be the future role of tissue-based biomarkers in HCC?


This e-learning course discusses the changing treatment landscape in hepatocellular carcinoma (HCC) and how therapy can be optimised for the individual patient. Key clinical questions will be addressed, including;
- When and how to transition from loco-regional to systemic therapy?
- What is the role of novel systemic therapies and immunotherapy?
- What is the impact of treatment sequencing?
During the e-learning, Experts will present different patient case studies to enhance your understanding of this area.

